From BYU PRISM

Projects: AI-Augmented Crystallization Control

This project explores the integration of generative AI into pharmaceutical crystallization control, tackling modern manufacturing challenges and enabling intelligent, autonomous process optimization.

Pharmaceutical Crystallization Challenges

Crystallization is essential in producing active pharmaceutical ingredients (APIs), determining purity, particle size, shape, and downstream performance. Yet, as detailed in a recent commentary from Nature Chemical Engineering A Changing Paradigm in Industrial Pharmaceutical Crystallization, the field is undergoing a shift:

This creates an urgent need for smarter control strategies—ones that can adapt in real time, learn from data, and incorporate physical knowledge.

Mission Statement

To develop a next-generation model predictive control (MPC) framework empowered by generative AI for real-time, self-improving control of pharmaceutical crystallization processes.

Project Objectives and Methods

1. Literature Review

2. Develop GenAI Agents

Phase 0: Simulation
Phase I: Continuous Crystallization

Phase II: Batch Crystallization

3. Human-in-the-Loop Interaction

4. Closed-Loop Demonstration

5. Integration with Control Platforms

6. Autonomous Learning and Optimization

Undergraduate Research Opportunity

Key Responsibilities:

Preferred Qualifications:

To apply, contact Jonathan Pershing or visit the PRISM Group site for more info.

Graduate Student Lead: Jonathan Pershing

Jonathan Pershing is a PRISM Group researcher in Chemical Engineering. He leads the AI-Augmented Crystallization Project and specializes in model predictive control, process modeling, and generative AI. Jonathan is passionate about tackling the unthinkably difficult through engineering, persistence, and innovation.

Research Assistant: Megan Booth

Megan Booth is an undergraduate research assistant contributing to the AI-Augmented Crystallization Project through her expertise in crystallization techniques and process optimization. Her background includes previous research in terahertz spectroscopy and organic synthesis, as well as leadership and service experience in Guatemala. Passionate about applications engineering, automation, and process control, Megan is driven by the opportunity to apply emerging technologies to real-world industrial challenges.

Stay Connected

Visit this page for updates on progress, results, and opportunities to get involved. The project will share findings, simulations, and open-source model components to advance the field of AI-integrated process control.

Retrieved from https://apm.byu.edu/prism/index.php/Projects/PharmaceuticalCrystallization
Page last modified on March 25, 2025, at 05:09 PM